A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

NCT06390410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency

Interventions

DRUG: Simufilam

Sponsor

Cassava Sciences, Inc.